 Sabrina Spencer
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 18 | 2025 | 592 | 4.170 |
Why?
| | Cyclin-Dependent Kinase 2 | 11 | 2025 | 39 | 3.820 |
Why?
| | DNA Replication | 5 | 2024 | 228 | 1.690 |
Why?
| | Cell Cycle Proteins | 5 | 2023 | 586 | 1.650 |
Why?
| | Cell Proliferation | 10 | 2025 | 2391 | 1.420 |
Why?
| | Cellular Senescence | 2 | 2023 | 181 | 1.320 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2023 | 117 | 1.290 |
Why?
| | Histones | 3 | 2024 | 588 | 1.250 |
Why?
| | Cyclin-Dependent Kinases | 4 | 2025 | 130 | 1.230 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2025 | 169 | 0.930 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2023 | 212 | 0.910 |
Why?
| | CDC2-CDC28 Kinases | 1 | 2023 | 20 | 0.880 |
Why?
| | Single-Cell Analysis | 6 | 2024 | 277 | 0.860 |
Why?
| | Cyclin E | 1 | 2023 | 23 | 0.850 |
Why?
| | Signal Transduction | 9 | 2025 | 4925 | 0.780 |
Why?
| | Mitosis | 4 | 2024 | 180 | 0.780 |
Why?
| | DNA Damage | 3 | 2024 | 384 | 0.770 |
Why?
| | Retinoblastoma Protein | 3 | 2018 | 54 | 0.740 |
Why?
| | Models, Biological | 7 | 2018 | 1722 | 0.720 |
Why?
| | Neoplasms | 4 | 2023 | 2470 | 0.710 |
Why?
| | Mitogens | 2 | 2020 | 58 | 0.700 |
Why?
| | Cell Tracking | 1 | 2020 | 14 | 0.690 |
Why?
| | Time-Lapse Imaging | 1 | 2020 | 20 | 0.690 |
Why?
| | G2 Phase | 1 | 2020 | 36 | 0.680 |
Why?
| | G1 Phase | 1 | 2020 | 70 | 0.670 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 400 | 0.610 |
Why?
| | Protein Kinase Inhibitors | 2 | 2023 | 891 | 0.610 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 109 | 0.590 |
Why?
| | Cell Survival | 4 | 2023 | 1086 | 0.580 |
Why?
| | Proteolysis | 1 | 2018 | 166 | 0.570 |
Why?
| | Oncogene Proteins | 1 | 2017 | 55 | 0.560 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 5 | 2013 | 43 | 0.560 |
Why?
| | Cell Line | 8 | 2025 | 2781 | 0.530 |
Why?
| | Cell Division | 5 | 2023 | 797 | 0.530 |
Why?
| | Neuroblastoma | 1 | 2017 | 154 | 0.520 |
Why?
| | Apoptosis | 5 | 2013 | 2503 | 0.500 |
Why?
| | Stem Cells | 1 | 2020 | 577 | 0.490 |
Why?
| | DNA | 2 | 2023 | 1400 | 0.490 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3215 | 0.470 |
Why?
| | Melanoma | 1 | 2021 | 730 | 0.440 |
Why?
| | Stress, Physiological | 1 | 2017 | 413 | 0.440 |
Why?
| | S Phase | 2 | 2024 | 75 | 0.440 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2006 | 328 | 0.420 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2548 | 0.410 |
Why?
| | Algorithms | 1 | 2020 | 1622 | 0.400 |
Why?
| | Hydrogels | 3 | 2025 | 638 | 0.400 |
Why?
| | MAP Kinase Signaling System | 2 | 2025 | 312 | 0.380 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2142 | 0.380 |
Why?
| | Polyethylene Glycols | 3 | 2025 | 601 | 0.350 |
Why?
| | Humans | 29 | 2025 | 129622 | 0.320 |
Why?
| | Up-Regulation | 2 | 2021 | 840 | 0.290 |
Why?
| | Neovascularization, Pathologic | 2 | 2006 | 297 | 0.280 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2025 | 177 | 0.280 |
Why?
| | Cell Cycle Checkpoints | 2 | 2024 | 95 | 0.270 |
Why?
| | Nuclear Proteins | 2 | 2023 | 663 | 0.250 |
Why?
| | Caspases | 4 | 2013 | 245 | 0.250 |
Why?
| | Carbonates | 1 | 2025 | 11 | 0.240 |
Why?
| | Transcription Factor TFIIH | 1 | 2025 | 40 | 0.230 |
Why?
| | Carbamates | 1 | 2025 | 46 | 0.230 |
Why?
| | Esters | 1 | 2025 | 74 | 0.230 |
Why?
| | Systems Biology | 1 | 2004 | 59 | 0.230 |
Why?
| | Phosphorylation | 3 | 2025 | 1713 | 0.220 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2024 | 44 | 0.220 |
Why?
| | Chromatin | 2 | 2024 | 479 | 0.220 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 101 | 0.220 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2025 | 274 | 0.220 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2023 | 73 | 0.220 |
Why?
| | Models, Genetic | 1 | 2006 | 594 | 0.210 |
Why?
| | Neoplasm Proteins | 1 | 2006 | 424 | 0.210 |
Why?
| | Leucine | 1 | 2023 | 108 | 0.210 |
Why?
| | Lysine | 2 | 2023 | 286 | 0.210 |
Why?
| | Methionine | 1 | 2023 | 158 | 0.210 |
Why?
| | Cell Differentiation | 2 | 2021 | 1902 | 0.200 |
Why?
| | Feedback | 1 | 2023 | 162 | 0.200 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 284 | 0.200 |
Why?
| | Oncogenes | 1 | 2023 | 113 | 0.200 |
Why?
| | Evolution, Molecular | 1 | 2006 | 466 | 0.200 |
Why?
| | Transcription Factors | 3 | 2025 | 1651 | 0.200 |
Why?
| | Azides | 1 | 2022 | 46 | 0.190 |
Why?
| | Cell Lineage | 2 | 2021 | 333 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2023 | 147 | 0.190 |
Why?
| | Mitochondrial Membranes | 3 | 2011 | 39 | 0.190 |
Why?
| | Activating Transcription Factor 4 | 1 | 2021 | 20 | 0.180 |
Why?
| | Research Report | 1 | 2021 | 76 | 0.180 |
Why?
| | Dexamethasone | 1 | 2023 | 346 | 0.180 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 95 | 0.180 |
Why?
| | Embryonic Development | 1 | 2021 | 114 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 511 | 0.170 |
Why?
| | Cyclin D | 1 | 2020 | 8 | 0.170 |
Why?
| | Mutagenesis | 1 | 2021 | 181 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2021 | 215 | 0.170 |
Why?
| | Amino Acids | 1 | 2023 | 485 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 131 | 0.160 |
Why?
| | Biosensing Techniques | 1 | 2020 | 120 | 0.160 |
Why?
| | Biomarkers | 2 | 2023 | 3973 | 0.160 |
Why?
| | Mutation | 3 | 2023 | 3717 | 0.150 |
Why?
| | MCF-7 Cells | 1 | 2018 | 116 | 0.150 |
Why?
| | Contact Inhibition | 1 | 2017 | 5 | 0.140 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2017 | 8 | 0.140 |
Why?
| | Cell Movement | 2 | 2020 | 945 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 406 | 0.140 |
Why?
| | Cyclin D1 | 1 | 2017 | 63 | 0.140 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 291 | 0.140 |
Why?
| | Animals | 9 | 2023 | 35360 | 0.140 |
Why?
| | Cdh1 Proteins | 1 | 2016 | 1 | 0.130 |
Why?
| | Anaphase-Promoting Complex-Cyclosome | 1 | 2016 | 5 | 0.130 |
Why?
| | Time Factors | 3 | 2020 | 6556 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2023 | 2708 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 887 | 0.120 |
Why?
| | 3T3 Cells | 1 | 2013 | 153 | 0.110 |
Why?
| | fas Receptor | 1 | 2013 | 95 | 0.100 |
Why?
| | Mice | 2 | 2023 | 16937 | 0.100 |
Why?
| | Permeability | 2 | 2009 | 157 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 182 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 271 | 0.090 |
Why?
| | HeLa Cells | 2 | 2009 | 608 | 0.090 |
Why?
| | Enzyme Activation | 2 | 2009 | 811 | 0.090 |
Why?
| | Pharmacological Phenomena | 1 | 2009 | 1 | 0.080 |
Why?
| | Cells | 1 | 2009 | 24 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2012 | 1198 | 0.080 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 11 | 0.080 |
Why?
| | Computer Simulation | 3 | 2012 | 943 | 0.080 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 29 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 267 | 0.070 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 759 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 513 | 0.070 |
Why?
| | Probability | 1 | 2009 | 306 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1356 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2013 | 4083 | 0.060 |
Why?
| | Computational Biology | 1 | 2010 | 599 | 0.060 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2024 | 12 | 0.060 |
Why?
| | Hydrolysis | 1 | 2025 | 186 | 0.060 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 178 | 0.050 |
Why?
| | Alkynes | 1 | 2022 | 55 | 0.050 |
Why?
| | Feedback, Physiological | 2 | 2014 | 77 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 366 | 0.050 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 613 | 0.040 |
Why?
| | Binding Sites | 1 | 2023 | 1252 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 575 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1418 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 193 | 0.040 |
Why?
| | Polymers | 1 | 2022 | 479 | 0.040 |
Why?
| | Proteomics | 1 | 2024 | 1062 | 0.040 |
Why?
| | RNA | 1 | 2023 | 883 | 0.030 |
Why?
| | Female | 1 | 2024 | 68770 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2016 | 26 | 0.030 |
Why?
| | S-Phase Kinase-Associated Proteins | 1 | 2014 | 20 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2014 | 77 | 0.030 |
Why?
| | Ubiquitination | 1 | 2014 | 98 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2014 | 55 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1480 | 0.030 |
Why?
| | Stochastic Processes | 1 | 2013 | 67 | 0.030 |
Why?
| | Phenotype | 2 | 2013 | 3076 | 0.030 |
Why?
| | Caspase Inhibitors | 1 | 2013 | 83 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 375 | 0.030 |
Why?
| | Kinetics | 1 | 2014 | 1642 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2013 | 265 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 653 | 0.020 |
Why?
| | Drug Therapy | 1 | 2009 | 80 | 0.020 |
Why?
| | Apoptosomes | 1 | 2008 | 1 | 0.020 |
Why?
| | Caspase 8 | 1 | 2008 | 48 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 296 | 0.020 |
Why?
| | Caspase 9 | 1 | 2008 | 56 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 354 | 0.020 |
Why?
| | Caspase 3 | 1 | 2008 | 245 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1706 | 0.020 |
Why?
| | Proteins | 1 | 2009 | 942 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2736 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|